Align Technology | ALGN - Ebitda

Cena Akcji
189.61
Dzienna Zmiana
-1.06 -0.56%
Miesięcznie
5.18%
Rocznie
3.41%
Q2 Prognozy TE
185.55




Ebitda Zmiana Data
3M USD 1.41B 267M 2025-12
Align Technology USD 183.84M 19.77M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Bruker USD 211.6M 207.4M 2025-12
Cardinal Health USD 981M 5M 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
CVS Health USD 3.74B 349M 2025-12
Danaher USD 1.92B 204M 2026-03
Dentsply International USD 135M 32M 2025-12
Dexcom USD 422.2M 53.8M 2025-12
Henry Schein USD 291M 4M 2025-12
Idexx Laboratories USD 391.47M 17.97M 2025-09
Insulet USD 194M 34M 2025-12
Integra LifeSciences USD 104.21M 25.76M 2025-12
IQVIA Holdings USD 1.05B 97M 2025-12
Masimo USD 91.9M 19.9M 2025-09
McKesson USD 1.68B 418M 2025-09
Mettler Toledo International USD 322.64M 26.75M 2025-09
Revvity USD 248.91M 48.52M 2025-12
Solventum Corp USD 437M 38M 2025-12
Stryker USD 1.67B 206M 2025-09
Teleflex USD -328.81M 536.43M 2025-09
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Veeva Systems USD 374.79M 3.96M 2025-12
Waters USD 380.97M 85.83M 2025-12
Zimmer Biomet Holdings USD 759M 120.8M 2025-12
Zoetis USD 1.04B 87M 2025-09